Biological Products, (No Diagnostic Substances) · CIK 1735438
Develops and manufactures genetic medicines for inherited and common conditions using proprietary platforms and in-house GMP manufacturing
Comparable business profile · signals at a glance
In the 90 days to Mar 24, 2026: 1 sold $459K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 24, 2026 | Forbes AlexandriaPRESIDENT & CEO | Sell | 62,000 | $7.41 | $459K |
| Oct 21, 2025 | Giroux RichardCFO & COO | Sell | 24,000 | $8.87 | $213K |
| Oct 7, 2025 | Forbes AlexandriaPRESIDENT & CEO | Sell | 47,500 | $8.39 | $399K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.